Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Handbook: Clinical Pharmacology of Anti-Cancer Agents - Reviewers

The editors and authors wish to thank the following reviewers.

G.J. Peters, EORTC-PAMM Chair, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands

Joan Albanell, University Hospital del Mar, Barcelona, Spain

J.H. Beijnen, Netherlands Cancer Institute, Amsterdam, The Netherlands

Massimo Broggini, Laboratory of Molecular Pharmacology, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy

Andrés Cervantes Ruiperez, Hospital Clinico Universitario de Valencia, Servicio de Hematologia y Oncologia Medica, Valencia, Spain

Michele Ghielmini, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

Marta Guix, University Hospital del Mar, Barcelona, Spain

Markus Jörger, Kantonsspital St. Gallen, St. Gallen, Switzerland

H.M. Lokhorst, University Medical Center Utrecht, Utrecht, The Netherlands

Curzio Rüegg, Department of Medicine, Faculty of Science, University of Fribourg, Germany

Alex Sparreboom, Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, USA

Josep Tabernero, Vall d’Hebron University Hospital, Oncologia Medica, Institut d’Oncologia, Barcelona, Spain

Editors and Contributors Acknowledgements

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings